C. S. Lewis’s Prophetic Legacy on Scientism
Thomas Aquinas Weighs in on the Coronavirus and Public Policy
On this episode of ID the Future, Andrew McDiarmid speaks with pediatric neurosurgeon and professor Michael Egnor about public policy decisions regarding the coronavirus. In a conversation based on a recent Evolution News article, Egnor says scientists should have “stayed in their lane,” giving policymakers the information that science can provide about a potential pandemic, and left the political calculations alone. He argues that WHO failed in one of its primary jobs, which is providing timely information and recommendations for preventing and slowing the spread of pandemics. They sat on information about Covid-19 for weeks, long after they knew there was a serious problem in China. Egnor also urges policymakers to apply science along with other expert information in a transparent decision-making process. And they must apply sound ethics — for which Egnor offers Thomas Aquinas’s four-fold framework, including the principle of “double effect.”
Covid-19, Random Mutations, and Aristotle’s Matrix of Design
On this episode of ID the Future, Andrew McDiarmid speaks with neurosurgeon Michael Egnor about Egnor’s recent Evolution News article, The Coronavirus Demonstrates How Evolution Presupposes Intelligent Design. Egnor notes that the coronavirus and other viruses are not, strictly speaking, considered living things, even if they depend on living hosts for their continued existence. Egnor also discusses the role of random mutations in viruses and draws upon Aristotle to argue that these and other random events only occur, and have their meaning, against a backdrop of purpose and design — in this case, the designed systems — the bodies — that viruses invade.
Evolution, ID, and the Coronavirus: Jonathan Wells Explains
On this episode of ID the Future, biologist and Discovery Institute senior fellow Jonathan Wells tackles questions of evolution and intelligent design as they relate to the novel coronavirus SARS CoV-2. Is it the product of evolution, in the sense of Darwin’s Origin of Species? Wells argues to the contrary: It’s not a new species; in fact viruses aren’t even considered living species. Does modern evolutionary theory guide medicine’s response? Not when you consider that most of the major treatments being used and pursued actually preceded Darwin. Is intelligent design involved? Yes and no, Wells says. Listen in to get his take on this and more.
Michael Behe on COVID-19, Chloroquine, Malaria and the Edge of Evolution
On this episode of ID the Future, biochemist Michael Behe and host Andrew McDiarmid discuss the anti-malarial drug chloroquine, now being investigated as a treatment for COVID-19, and how it may work on the cellular level against the coronavirus. The same drug was featured in Behe’s 2007 book The Edge of Evolution, as part of his demonstration that evolution has strict limits: It can do adaptive work for organisms with single mutations, but if just two coordinated mutations are required at once, evolution’s random processes have great difficulty even with natural selection helping them along. In cases where population sizes are enormous, as with malaria, it can eventually overcome the need for two simultaneous and coordinated mutations, but only just barely. Because the odds go up exponentially, three simultaneous coordinated mutations may be beyond the edge of evolution. What does all this bode for chloroquine and the coronavirus? Listen in as McDiarmid and Behe discuss.